TITLE

GUEST COMMENTARIES

AUTHOR(S)
Blum, Joanne L.
PUB. DATE
July 1999
SOURCE
Drugs;Jul1999, Vol. 58 Issue 1, p77
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the use of tumor-selective fluoropyrimidine carbamate, capecitabine for the treatment of metastatic breast cancer. Approval of the drug by the U.S. Food and Drug Administration; Clinical trial performed on patients with disease progression treated with capecitabine; Adverse-effects associated with the drug's consumption.
ACCESSION #
9523852

 

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics